Does Harvoni cure hepatitis C in 8 weeks?
Harvoni (ledipasvir/sofosbuvir) is designed to cure hepatitis C in many people, but an “8-week” cure depends on the specific hepatitis C type and your treatment history. The drug is commonly used for either an 8-week or 12-week course, with 8 weeks generally reserved for certain groups who meet eligibility criteria.
Whether an 8-week course is appropriate (and whether it cures you) is determined by factors such as the hepatitis C genotype, how much virus is in your blood early in treatment, whether you have cirrhosis, and whether you previously received hepatitis C treatment.
When is an 8-week Harvoni course used?
An 8-week duration is typically used for people with hepatitis C genotype 1 who meet criteria like being treatment-naive (never treated before) and not having cirrhosis, or having other specific low-risk features depending on the regimen being used. People with more advanced liver disease or prior treatment failures are more likely to be prescribed a longer course.
If you have not been assigned an exact regimen and treatment plan, you should not assume 8 weeks will be enough.
How do doctors judge whether Harvoni “cures” hepatitis C?
Clinicians define a cure as achieving a sustained virologic response (SVR), meaning the hepatitis C virus is undetectable in blood after treatment and remains undetectable for a follow-up period. That SVR status is what confirms cure, not just whether the virus drops during treatment.
What happens if hepatitis C is still detectable at the end of 8 weeks?
If the hepatitis C virus is still detectable near the end of treatment, you may need an extended regimen or a different combination/strategy. The exact next step depends on why the virus is not cleared (for example, baseline liver damage, genotype nuances, adherence, and prior drug exposure).
Can 8 weeks work for people with cirrhosis or other complications?
Cirrhosis can make clearance less certain in some groups, and many prescribing pathways use longer treatment when cirrhosis is present or when there are other higher-risk features. So the “8-week cure” idea is not universally true.
What patients usually ask next: “What should I check to know if I qualify for 8 weeks?”
You’ll want your clinician to confirm:
- Your hepatitis C genotype
- Whether you have cirrhosis (and how severe)
- Whether you’re treatment-naive or previously treated
- Your early and end-of-treatment viral load results
- Any drug interactions that could affect Harvoni levels or effectiveness
If you share your genotype, whether you have cirrhosis, and whether you’ve been treated before, I can explain how those factors generally affect whether 8 weeks is used.
Sources
Sources are not available in the provided information.